These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20404127)

  • 21. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
    Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
    Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosis.
    Sherrard LJ; Graham KA; McGrath SJ; McIlreavey L; Hatch J; Muhlebach MS; Wolfgang MC; Gilpin DF; Elborn JS; Schneiders T; Tunney MM
    J Antimicrob Chemother; 2013 Oct; 68(10):2369-74. PubMed ID: 23696621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic susceptibility of alpha- and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(2):123-31. PubMed ID: 9084921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotyping and susceptibility to macrolides and other antimicrobial drugs of Streptococcus pyogenes isolated from patients with invasive diseases in southern Israel.
    Weiss I; Gorodnitzky Z; Korenman Z; Yagupsky P
    Eur J Clin Microbiol Infect Dis; 1997 Jan; 16(1):20-3. PubMed ID: 9063669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of several macrolides and a ketolide against clinically isolated 'Streptococcus milleri' group.
    Yamamoto N; Fujita J; Higa F; Tateyama M; Nakasone I; Yamane N
    Int J Antimicrob Agents; 2006 Mar; 27(3):253-5. PubMed ID: 16472994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial resistance profile and multidrug resistance patterns of Streptococcus pneumoniae isolates from patients suspected of pneumococcal infections in Ethiopia.
    Sharew B; Moges F; Yismaw G; Abebe W; Fentaw S; Vestrheim D; Tessema B
    Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):26. PubMed ID: 33879172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides.
    Wierzbowski AK; Boyd D; Mulvey M; Hoban DJ; Zhanel GG
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4635-40. PubMed ID: 16251306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility profiles of oropharyngeal viridans group streptococci isolates from cystic fibrosis and non-cystic fibrosis patients.
    Alvarez M; Alvarez ME; Máiz L; Asensio A; Baquero F; Canton R
    Microb Drug Resist; 1998; 4(2):123-8. PubMed ID: 9650999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR; Pressler T; Hoiby N; Johansen HK
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative potency of telithromycin, azithromycin and erythromycin against recent clinical isolates of gram-positive cocci.
    Barry AL; Fuchs PC; Brown SD
    Eur J Clin Microbiol Infect Dis; 2001 Jul; 20(7):494-7. PubMed ID: 11561807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae.
    Jorgensen JH; Swenson JM; Tenover FC; Barry A; Ferraro MJ; Murray PR; Reller LB
    J Clin Microbiol; 1996 Nov; 34(11):2679-84. PubMed ID: 8897164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The trend of macrolide resistance and emm types of group A streptococci from children at a medical center in southern Taiwan.
    Chuang PK; Wang SM; Lin HC; Cho YH; Ma YJ; Ho TS; Shen CF; Liu CC
    J Microbiol Immunol Infect; 2015 Apr; 48(2):160-7. PubMed ID: 24094501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK
    Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients.
    Sherrard LJ; Schaible B; Graham KA; McGrath SJ; McIlreavey L; Hatch J; Wolfgang MC; Muhlebach MS; Gilpin DF; Schneiders T; Elborn JS; Tunney MM
    J Antimicrob Chemother; 2014 Oct; 69(10):2690-8. PubMed ID: 24917582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired resistance to macrolides in
    Mustafa MH; Khandekar S; Tunney MM; Elborn JS; Kahl BC; Denis O; Plésiat P; Traore H; Tulkens PM; Vanderbist F; Van Bambeke F
    Eur Respir J; 2017 May; 49(5):. PubMed ID: 28526799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial activity of dalbavancin and comparators against Staphylococcus aureus causing pneumonia in patients with and without cystic fibrosis.
    Sader HS; Duncan LR; Mendes RE
    Int J Infect Dis; 2021 Jun; 107():69-71. PubMed ID: 33878463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Streptococcus milleri group in chronic obstructive pulmonary disease.
    Navratilova L; Bardon J; Novotny R; Zatloukal J; Jakubec P; Kolek V; Zapalka M; Kopriva F; Prochazkova P; Raclavsky V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):378-84. PubMed ID: 27132809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SUSCEPTIBILITY OF RESPIRATORY ISOLATES OF STREPTOCOCCUS PNEUMONIAE ISOLATED FROM CHILDREN HOSPITALIZED IN THE CLINICAL CENTER NIS.
    Dinić MM; Mladenović Antić S; Kocić B; Stanković Dordević D; Vrbić M; Bogdanović M
    Med Pregl; 2016; 69(3-4):110-4. PubMed ID: 27506099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
    Vallianou N; Evangelopoulos A; Hadjisoteriou M; Avlami A; Petrikkos G
    J Chemother; 2015; 27(6):319-23. PubMed ID: 25112954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.